Home Cart Sign in  
Chemical Structure| 1282512-48-4 Chemical Structure| 1282512-48-4

Structure of Taselisib
CAS No.: 1282512-48-4

Chemical Structure| 1282512-48-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Taselisib (GDC-0032) is a potent PI3K inhibitor targeting PIK3CA mutations, with Ki values of 0.12 nM for PI3Kδ, 0.29 nM for PI3Kα, 0.97 nM for PI3Kγ, and 9.1 nM for PI3Kβ.

Synonyms: GDC-0032; RG-7604; GDC0032, GDC0032, GDC 0032, RG7604, RG7604, RG 7604, Taselisib

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Taselisib

CAS No. :1282512-48-4
Formula : C24H28N8O2
M.W : 460.53
SMILES Code : O=C(N)C(C)(C)N1N=CC(C2=CC=C3C4=NC(C5=NC(C)=NN5C(C)C)=CN4CCOC3=C2)=C1
Synonyms :
GDC-0032; RG-7604; GDC0032, GDC0032, GDC 0032, RG7604, RG7604, RG 7604, Taselisib
MDL No. :MFCD28167893
InChI Key :BEUQXVWXFDOSAQ-UHFFFAOYSA-N
Pubchem ID :51001932

Safety of Taselisib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Taselisib

PI3K-AKT

Isoform Comparison

Biological Activity

Target
  • p110γ

    PI3Kγ, Ki:0.97 nM

  • p110β

    PI3Kβ, Ki:9.1 nM

  • C2β

    C2β, IC50:292 nM

  • p110α

    PI3Kα, Ki:0.29 nM

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT04439175 Advanced Lymphoma|Advanced Mal... More >>ignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma Less << PHASE2 ACTIVE_NOT_RECRUITING 2025-03-07 ECOG-ACRIN Cancer Research Gro... More >>up, Philadelphia, Pennsylvania, 19103, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.17mL

0.43mL

0.22mL

10.86mL

2.17mL

1.09mL

21.71mL

4.34mL

2.17mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories